Fingerprint
Dive into the research topics of 'Ustekinumab as induction and maintenance therapy for Crohn's disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ustekinumab as induction and maintenance therapy for Crohn's disease
UNITI-IM-UNITI Study Group
- Western University
- University of California at San Diego
- Johnson & Johnson
- Janssen Scientific Affairs, LLC
- Icahn School of Medicine at Mount Sinai
- Northwestern University
- KU Leuven
- Cedars-Sinai Medical Center
- University of Calgary
- Stellenbosch University
- Semmelweis University
- Hannover Medical School
- Atlanta Gastroenterology Specialists PC
- Université de Lille
- University of Washington
- Mayo Clinic Rochester, MN
- University of Alberta
- New York University
Research output: Contribution to journal › Article › peer-review
1440
Scopus
citations